{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:06:57Z","timestamp":1787022417628,"version":"build-2736575974"},"reference-count":21,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej19-0278","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T18:29:56Z","timestamp":1570645796000},"page":"81-89","source":"Crossref","is-referenced-by-count":25,"title":["Development and validation of a clinical model to predict intraoperative hemodynamic instability in patients with pheochromocytomas surgery"],"prefix":"10.1507","volume":"67","author":[{"given":"Song","family":"Bai","sequence":"first","affiliation":[{"name":"Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichuan","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Kopetschke R, Slisko M, Kilisli A, Tuschy U, Wallaschofski H, et al. (2009) Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. Eur J Endocrinol 161: 355\u2013361.","DOI":"10.1530\/EJE-09-0384"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Young WF Jr (2000) Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29: 159\u2013185, x.","DOI":"10.1016\/S0889-8529(05)70122-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Lenders JW, Eisenhofer G, Mannelli M, Pacak K (2018) Phaeochromocytoma. Lancet 366: 665\u2013675.","DOI":"10.1016\/S0140-6736(05)67139-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Jiang M, Ding H, Liang Y, Tang J, Lin Y, et al. (2018) Preoperative risk factors for haemodynamic instability during pheochromocytoma surgery in Chinese patients. Clin Endocrinol 88: 498\u2013505.","DOI":"10.1111\/cen.13544"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Kiernan CM, Du L, Chen X, Broome JT, Shi C, et al. (2014) Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol 21: 3865\u20133871.","DOI":"10.1245\/s10434-014-3847-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Chang RY, Lang BH, Wong KP, Lo CY (2014) High pre-operative urinary norepinephrine is an independent determinant of peri-operative hemodynamic instability in unilateral pheochromocytoma\/paraganglioma removal. World J Surg 38: 2317\u20132323.","DOI":"10.1007\/s00268-014-2597-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Bruynzeel H, Feelders RA, Groenland TH, van den Meiracker AH, van Eijck CH, et al. (2010) Risk factors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endocrinol Metab 95: 678\u2013685.","DOI":"10.1210\/jc.2009-1051"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Karakiewicz PI, Briganti A, Chun FK, Trinh QD, Perrotte P, et al. (2007) Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol 25: 1316\u20131322.","DOI":"10.1200\/JCO.2006.06.1218"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Brunaud L, Nguyen-Thi PL, Mirallie E, Raffaelli M, Vriens M, et al. (2016) Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients. Surg Endosc 30: 1051\u20131059.","DOI":"10.1007\/s00464-015-4294-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49: 1373\u20131379.","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Bai S, Yao Z, Zhu X, Li Z, Jiang Y, et al. (2019) Risk factors for postoperative cardiovascular morbidity after pheochromocytoma surgery: a large single center retrospective analysis. Endocr J 66: 165\u2013173.","DOI":"10.1507\/endocrj.EJ18-0402"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Bai S, Yao Z, Zhu X, Li Z, Jiang Y, et al. (2018) Risk factors for postoperative severe morbidity after pheochromocytoma surgery: a single center retrospective analysis of 262 patients. Int J Surg 60: 188\u2013193.","DOI":"10.1016\/j.ijsu.2018.11.019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Stolk RF, Bakx C, Mulder J, Timmers HJ, Lenders JW (2013) Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines? J Clin Endocrinol Metab 98: 1100\u20131106.","DOI":"10.1210\/jc.2012-3669"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Zhang R, Gupta D, Albert SG (2017) Pheochromocytoma as a reversible cause of cardiomyopathy: analysis and review of the literature. Int J Cardiol 249: 319\u2013323.","DOI":"10.1016\/j.ijcard.2017.07.014"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Scholten A, Vriens MR, Cromheecke GJ, Borel Rinkes IH, Valk GD (2011) Hemodynamic instability during resection of pheochromocytoma in MEN <i>versus<\/i> non-MEN patients. Eur J Endocrinol 165: 91\u201396.","DOI":"10.1530\/EJE-11-0148"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17 Bozkurt IH, Arslan M, Yonguc T, Degirmenci T, Koras O, et al. (2015) Laparoscopic adrenalectomy for large adrenal masses: is it really more complicated? Kaohsiung J Med Sci 31: 644\u2013648.","DOI":"10.1016\/j.kjms.2015.09.005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18 Guerrero MA, Schreinemakers JM, Vriens MR, Suh I, Hwang J, et al. (2009) Clinical spectrum of pheochromocytoma. J Am Coll Surg 209: 727\u2013732.","DOI":"10.1016\/j.jamcollsurg.2009.09.022"},{"key":"18","doi-asserted-by":"publisher","unstructured":"20 Mazza A, Armigliato M, Marzola MC, Schiavon L, Montemurro D, et al. (2014) Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features. Endocrine 45: 469\u2013478.","DOI":"10.1007\/s12020-013-0007-y"},{"key":"19","doi-asserted-by":"crossref","unstructured":"21 Pacak K (2007) Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 92: 4069\u20134079.","DOI":"10.1210\/jc.2007-1720"},{"key":"20","doi-asserted-by":"crossref","unstructured":"22 Prys-Roberts C, Farndon JR (2002) Farndon, efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg 26: 1037\u20131042.","DOI":"10.1007\/s00268-002-6667-z"},{"key":"21","doi-asserted-by":"crossref","unstructured":"23 Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD). Ann Intern Med 162: 735\u2013736.","DOI":"10.7326\/L15-5093-2"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/1\/67_EJ19-0278\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T22:42:32Z","timestamp":1580510552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/1\/67_EJ19-0278\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej19-0278","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}